reports
Duratec Limited: 2 directors
Two Directors at Duratec Limited bought 44,000 shares at between 1.050AUD and 1.050AUD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...
Eniro Group AB: 1 director
A director at Eniro Group AB sold 115,000,000 shares at 0.900SEK and the significance rating of the trade was 86/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Believe S A: 1 director
A director at Believe S A sold 11,684,314 shares at 15.000EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Heal...
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference BOSTON and ROLLE, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced that Chief Financial Officer and Chief Operating Officer, Ross Muken, will present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City on Tuesday, May 14, 2024, at 3:35 p.m. EDT. The presentation will be webcast live on the . Additionally, a replay will be available on the website after its completion. About ...
Harmony Biosciences Reports Strong First Quarter Financial Results and...
Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy WAKIX® (pitolisant) Net Revenue of $154.6 Million for First Quarter 2024; ~30% Growth Year-over-Year Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia Planned for Second Half 2024 On Track Toward Pediatric Exclusivity to Extend WAKIX Exclusivity to September 2030: Pediatric Narcolepsy sNDA PDUFA Date of June 21, 2024; PW...
Clearside Biomedical to Report First Quarter 2024 Financial Results an...
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 ALPHARETTA, Ga., April 30, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that its first quarter 2024 financial results will be reported on Thursday, May 9, 2024 after the close of the financial markets. Management will host a webcast and conference call at 4:30 p.m. Eastern Time to discuss the result...
Inari Amertron Bhd: 1 director
A director at Inari Amertron Bhd sold 2,000,000 shares at 0.000MYR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Change in number of shares and votes in HMS Networks
Change in number of shares and votes in HMS Networks As previously announced, HMS Networks has carried out a directed share issue. The directed share issue has resulted in a change in the number of shares and votes in HMS Networks. Prior to the directed share issue, the total number of shares in HMS Networks amounted to 46,818,868, corresponding to 46,818,868 votes. The number of shares and votes has as a result of the directed share issue increased by 3,500,000. As of April 30, 2024, the total number of shares in HMS Networks amounts to 50,318,868, corresponding to 50,318,868 votes.1 ...
Förändring av antalet aktier och röster i HMS Networks
Förändring av antalet aktier och röster i HMS Networks HMS Networks har som tidigare offentliggjorts genomfört en riktad nyemission av aktier. Emissionen har resulterat i en förändring av antalet aktier och röster i HMS Networks. Före emissionen fanns sammanlagt 46 818 868 aktier i HMS Networks, motsvarande 46 818 868 röster. Antalet aktier och röster har genom emissionen ökat med 3 500 000. Per den 30 april 2024 finns det sammanlagt 50 318 868 aktier i HMS Networks, motsvarande 50 318 868 röster.1 För mer information, vänligen kontakta:Staffan Dahlström, VD HMS, ...
KKR’s Henry McVey Says Insurance CIOs Plan to Increase Allocations to ...
NEW YORK--(BUSINESS WIRE)-- KKR, a leading global investment firm, today released “No Turning Back,” a new Insights piece by Henry McVey, CIO of KKR’s Balance Sheet and Head of Global Macro and Asset Allocation (GMAA). Based on a proprietary survey of nearly 50 Chief Investment Officers (CIOs) who collectively oversee over more than $8 trillion dollars in assets, the report examines how leading insurance companies are navigating and evolving their asset allocation priorities for today’s more volatile interest rate environment. Specifically, McVey notes that allocations to non-traditional inv...
Solaris Announces Award of Option to Acquire Key Concessions Hosting P...
Solaris Announces Award of Option to Acquire Key Concessions Hosting Porphyry Copper and Epithermal Gold Potential Adjacent to Warintza VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) is pleased to announce that the Ecuadorian state-owned mining company, Empresa Nacional Minera (“ENAMI EP”), has awarded the Company an option to acquire up to a 100% interest in 10 new explorations concessions. These concessions comprise a land package of ~40,000 hectares adjacent to the Warintza Project (“Warintza” o...
Skye Bioscience to Present Two Posters at Association for Research in ...
Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today announced that it will present two posters at the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting being held May 5-9, 2024, in Seattle, Washington. Details of the...
ATHA Energy Completes Angilak Project Equipment and Supply Mobilizatio...
ATHA Energy Completes Angilak Project Equipment and Supply Mobilization, Update on Commencement of Diamond Drilling HIGHLIGHTS: The Company has completed its equipment and supply mobilization to its 100%-owned Angilak Project in Nunavut, Canada.Mobilization included the delivery of two X10 Diamond Drills (), which are anticipated to nearly double daily meterage production compared to previous drilling campaigns conducted on the Angilak Project.The mobilization was completed in support of the 2024 Exploration Program at the Angilak Project, scheduled to commence Phase I (Diamond Drilling)...
ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Option...
ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab ASLAN management will present new data from the interim analysis of the TREK-DX studyRegister to attend the webinar event on May 7, 2024 at 8:00 AM ET SAN MATEO, Calif. and SINGAPORE, April 30, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that it will host a virtual Key Opinio...
Capital Product Partners L.P. Announces First Quarter 2024 Financial R...
Capital Product Partners L.P. Announces First Quarter 2024 Financial Results ATHENS, Greece, April 30, 2024 (GLOBE NEWSWIRE) -- Capital Product Partners L.P. (the “Partnership”, “CPLP” or “we” / “us”) (NASDAQ: CPLP), an international owner of ocean-going vessels, today released its financial results for the first quarter ended March 31, 2024. Highlights Three-month periods ended March 31, 20242023Increase / (Decrease)Revenues$104.5 million$81.0 million29%Expenses$54.9 million$45.1 million22%Interest expense and finance cost$34.0 million$23.7 million43%Net Income$33.9 million$10.0 millio...
Atico Updates Mineral Reserves and Resources for the El Roble Mine in ...
Atico Updates Mineral Reserves and Resources for the El Roble Mine in Colombia VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) is pleased to report of an updated NI 43-101 mineral resource and reserve estimate as on March 12th 2024 for the El Roble Mine located in Colombia. “Our infill and mine vicinity exploration drilling at El Roble mine has yielded very good results intercepting additional high-grade mineralization in proximity to current mining activity. What is particularly exciting is t...
First National Corporation Reports First Quarter Financial Results
First National Corporation Reports First Quarter Financial Results STRASBURG, Va., April 30, 2024 (GLOBE NEWSWIRE) -- First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank holding company of First Bank (the “Bank”), reported unaudited consolidated net income of $3.2 million and diluted earnings per common share of $0.51 for the three months ended March 31, 2024. FIRST QUARTER HIGHLIGHTS Key highlights of the three months ended March 31, 2024 are as follows. Comparisons are to the three-month period ended December 31, 2023, unless otherwise stated: Retu...
Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2...
Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024 SAN FRANCISCO, April 30, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today it will release first quarter 2024 results after the market closes on Monday, May 13, 2024. Following the release, management will host a conference call that same day at 1:30 p.m. PT / 4:30 p.m. ET. Live conference call: 877-407-3982 (Toll-Free) and 201-493-6780 (International)Live webcast: An archived replay will be available following the call on Augmedix’s IR webs...
Climb Channel Solutions' Commitment to Excellence Recognized with Mult...
Climb Channel Solutions' Commitment to Excellence Recognized with Multiple Prestigious Awards in Q1 2024 EATONTOWN, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) is proud to announce its exceptional recognition in the first quarter of 2024 with ten awards from industry leaders. The recognition reaffirms Climb Channel Solutions' dedication to delivering unparalleled service and support to its partners and customers across the globe. "We are ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.